Terms: = Bone cancer AND NSD1, FLJ44628, 64324, ENSG00000165671, Q96L73, FLJ22263, DKFZp666C163, ARA267, STO, SOTOS AND Treatment
5 results:
1. Mixed phenotype acute leukemia in a child associated with a NUP98-nsd1 fusion and NRAS p.Gly61Arg mutation.
Ganapathi SS; Raikar SS; Yatsenko SA; Djokic M; Bukowinski A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1372. PubMed ID: 33784031
[TBL] [Abstract] [Full Text] [Related]
2. Dasatinib and navitoclax act synergistically to target NUP98-nsd1
Kivioja JL; Thanasopoulou A; Kumar A; Kontro M; Yadav B; Majumder MM; Javarappa KK; Eldfors S; Schwaller J; Porkka K; Heckman CA
Leukemia; 2019 Jun; 33(6):1360-1372. PubMed ID: 30568173
[TBL] [Abstract] [Full Text] [Related]
3. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
Whang YM; Park SI; Trenary IA; Egnatchik RA; Fessel JP; Kaufman JM; Carbone DP; Young JD
Oncogene; 2016 Feb; 35(7):856-66. PubMed ID: 26119936
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Cary RL; Waddell S; Racioppi L; Long F; Novack DV; Voor MJ; Sankar U
J Bone Miner Res; 2013 Jul; 28(7):1599-610. PubMed ID: 23408651
[TBL] [Abstract] [Full Text] [Related]
5. In vitro colony forming cells and colony stimulating factor in chronic granulocytic leukaemia.
Goldman JM; Th'ng KH; Lowenthal RM
Br J Cancer; 1974 Jul; 30(1):1-12. PubMed ID: 4528599
[TBL] [Abstract] [Full Text] [Related]
